Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS03 Adjuvanted H5N1 Vaccine Immune Response Study
NCT01578317Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2012
- Primary completion
- Jan 2016
- Countries
- 1
01
Overview
A Phase 2 trial of AS03 in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2012; status: completed.
02
Drugs
AS03
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01578317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01578317.